Culturally grounded ENDS prevention for rural Hawaiian youth
Official title: The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth
Funded at University of Hawaii at Manoa · NIH-11378187 · Data updated 2026-11-12
A culturally tailored program will be created and tested to help rural Hawaiian youth avoid using electronic nicotine products.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $598,666 |
| NIH project number | 5R01DA054215-05 |
| Project ID | NIH-11378187 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are middle or intermediate school students in rural Hawai'i, especially those of Hawaiian or Pacific Islander ancestry.
✕Less likely to help
Youth outside rural Hawai'i or those not exposed to ENDS risk environments may see limited benefit.
What this research studies
This project focuses on developing and testing an ENDS prevention program specifically for youth in rural Hawai'i. Researchers will gather input from local youth to understand environmental pressures and risk situations that lead to ENDS use. They will identify common problem scenarios from multiple schools and design targeted prevention activities for Year 3. The study uses focus groups, surveys with hundreds of students, and iterative program development to ensure relevance to Hawaiian communities.
Why it matters
Potential benefit: If successful, the program could reduce ENDS use among rural Hawaiian youth and improve health outcomes.
How similar studies have gone: Other ENDS prevention efforts show promise when culturally tailored to specific communities, though this is a novel focus for rural Hawai'i youth.
Where this research is happening
-
University of Hawaii at Manoa
Honolulu, United States Active
Researchers
- Principal investigator: Okamoto, Scott Kiyoshi — University of Hawaii at Manoa
- Study coordinator: Okamoto, Scott Kiyoshi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.